-
Recent Posts
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
- Timeless Good Advice? (Action for Happiness)
- The Diversionary Value of Music Playlists for Patients With Dementia in Accident and Emergency Settings (Nurses.co.uk / BBC News)
Archives
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Knowledge Networks
Public Health England’s Research and Innovation Strategy (PHE / NHS IQ)
Summary Public Health England (PHE) have released their strategy for research, development and innovation, following a consultation. The set of seven PHE priorities have been resolved across five broader high level strategic constructs. Topic headings in this report comprise: The … Continue reading →
Posted in Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Patient Care Pathway, Public Health England, Quick Insights, Standards, Statistics, UK, Universal Interest
|
Tagged Academic Health Science Networks (AHSNs), Academic Public Health Research Support Network, Andrew Lambe: NHS IQ's Knowledge and Intelligence Team, ‘Social Science Shaping Society, Best Research for Best Health, Better Knowledge Better Care (BKBC), Birmingham University, BKBC: Better Knowledge Better Care (NHS IQ), Cambridge MRC Biostatistics Unit, Cambridge Veterinary School, Childhood Obesity, Cigarette Smoking, CLAHRC: Collaboration for Leadership in Applied Health Research and Care, Clinical Practice Research Datalink (CPRD), Clinical Research Networks (CRNs), Collaborations for Leadership in Applied Health Research and Care (CLAHRCs), Davenport on KM, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Empire Building, Epidemiology, Epidemiology and Statistics, Evidence Into Action (PHE), Exeter University, Global Burden of Disease (GBD), Health and Social Care Information Centre (HSCIC), Health and Wellbeing, Health Equity, Health Inequalities, Health Protection Research Units (HPRUs), Healthy Life Expectancy, Healthy Lifestyles, HEE Research and Innovation Strategy, Imperial College London, Imperial College NHS Trust, Inequality in Healthy Life Expectancy, Institute of Food Research, Integrated Knowledge Translation (IKT), Irresponsible Drinking, JLA PSP: James Lind Alliance Priority-Setting Partnership, Joanne Loughlin-Ridley: NHS IQ’s Knowledge and Intelligence Team, Kings College London, Knowledge Conversion, Knowledge Cycle, Knowledge Management (KM), Knowledge Networks, Knowledge Translation, Knowledge Translation Theory, Knowledge Workers, Learning and Clinical Networks, Learning Culture, Lifestyle Risk Factors, Living Longer: Reducing Avoidable Premature Mortality, Living Well for Longer, Local Public Health, Local Public Health Services, Local Public Health System Functions, London School of Hygiene and Tropical Medicine, Midlife Obesity, Modifiable Risk Factors, National Prevention Research Initiative (NPRI), Newcastle University, NHS England’s Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Improving Quality (NHS IQ), NHS IQ, NHS IQ’s Knowledge and Intelligence Team, NHS Preventative Services, NIHR Health Informatics Collaborative (NIHR HIC), NIHR Health Protection Research Unit (HPRU) Initiative, NIHR Health Protection Research Units, NIHR HPRU: NIHR Health Protection Research Unit, NIHR HPRUs, NIHR School for Primary Care Research, NIHR School for Public Health Research, NIHR School for Public Health Research (SPHR), NIHR School for Social Care Research, NIHR SPHR: NIHR School for Public Health Research, NOCRI: NIHR Office for Coordination of Clinical Research Infrastructure, NWL Academic Health Science Network, Obesity, Obesity Epidemic, Obesity Time-Bomb, Organisational Knowledge Management, PHE Intervention Evaluation Process, PHE Knowledge Management Framework, PHE Publication Standard Process, PHE R&D Group, PHE Research and Innovation Strategy, PHE Research and Innovation Strategy: Priority Five. Communication, PHE Research and Innovation Strategy: Priority Four. Innovation, PHE Research and Innovation Strategy: Priority One. Knowledge, PHE Research and Innovation Strategy: Priority Three. Capacity, PHE Research and Innovation Strategy: Priority Two. Infrastructure, PHE: Public Health England, PHE’s Knowledge Strategy, PHE’s Research Strategy, Preventable Mortality, Preventative Care, Preventative Services, Prevention of Tobacco Related Diseases, Problem Drinking, Protecting and Improving the Nation’s Health (PHE), Public Health, Public Health England (PHE), Public Health England: Research and Innovation Strategy (2015), Public Health Knowledge Cycle, Public Health Outcomes Framework, Public Health Workforce Strategy, Research and Innovation, Research Changes Lives, Research Networks, Research Priorities and Networks, Research Translation and Innovation, Smoking-Related Mortality, Social Deprivation, Social Determinants of Health, Social Determinants of Health Inequalities, Social Economic and Environmental Determinant, Social Epidemiology, Social Inequality, Supporting Research and Innovation, Translational Research, UKCRC Centres of Excellence in Public Health, UKCRC: UK Clinical Research Collaboration, University College London, University College London London, University of Bristol, University of East Anglia, University of Liverpool, University of Liverpool: Liverpool School of Tropical Medicine, University of Oxford, University of Oxford Animal and Plant Health Agency, University of the West of England, Wellbeing, Wellcome Sanger Institute, Wellness and Resilience
|
Leave a comment
UK-Based Drug Discovery Alliance (BBC News / Alzheimer’s Research UK)
Summary Alzheimer’s Research UK has announced the launch of the Drug Discovery Alliance, a £30 million network of research centres working collaboratively on research to discover potential cures, or at least disease modifying treatments, for Alzheimer’s Disease and other forms … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, For Researchers (mostly), In the News, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest
|
Tagged Academia-Industry Partnerships, Academia-Industry Synergies, Alzheimer’s Research UK Drug Discovery Institute, Alzheimer’s Research UK’s Drug Discovery Alliance, Big Pharma, Cambridge Biomedical Campus, Cambridge Drug Discovery Institute, Cambridge University, Clinical Research Networks, Collaborative Drug Discovery Programmes, Commissioning Research, Crowd-Sourced Information, Crowdsourcing, Dementia Research, Dementia Research Priorities, Dementia Research: UK Impact, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Eric Karran: Director of Research at Alzheimer’s Research UK, Dr Laura Phipps: Alzheimer’s Research UK, Drug Discovery Alliance, Drug Discovery Institute, Drug Discovery Institutes, Drug Discovery Programmes, Drugs for Treatment of Alzheimer’s Disease, Experimental Alzheimer's Drugs, First G8 Dementia Summit, G8 Dementia Summit, Genetic Research, Genetic Triggers, Global Action Against Dementia, Global Clinical Development Fund, Global Context, Global Dementia Legacy Event, Global Leadership, Global Outlook, Gurdon Institute: University of Cambridge, Innovation in Genetics, International Collaborations, International Organisations, International Programmes, Knowledge Networks, Knowledge Translation, Medical Research, MIT Sloan School of Management: Model for Public-Private Partnerships in Funding Research, Multidisciplinary Research Teams, Networks, Networks and Alliances, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Oxford Drug Discovery Institute, Oxford University, Parallel Discovery of Alzheimer’s Therapeutics (MIT Sloan and University of California Model), Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Pharmacological Research, Philanthropic Funding, Philanthropy, Prof. David Rubinsztein: Lead Academic Scientist at Cambridge Drug Discovery Institute, Prof. Giampietro Schiavo: Co-Lead Academic Scientist at UCL Drug Discovery Institute, Prof; Simon Lovestone: Co-Lead Academic Scientists at Oxford Drug Discovery Institute, Research Commitment, Research Consortia, Research Culture, Research Mapping, Research Networks, Research Programmes, Scientific Management Board of the Drug Discovery Institute, Stem Cell Research, Translational Research, UCL Drug Discovery Institute, University College London (UCL), University of Cambridge, University of Oxford
|
Leave a comment
Second Global Dementia Legacy Event: Ottawa, September 11th/12th 2014 (Department of Health / Dementia Challenge / World Dementia Council / CIHR / AVIESAN)
Summary Canada and France are co-hosting the second Global Action Against Dementia Legacy Event in Ottawa (Canada) on September 11th – 12th 2014. This event will explore how to take advantage of partnership working and collaboration between industry and academia, … Continue reading →
Posted in Acute Hospitals, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Universal Interest
|
Tagged Academia-Industry Partnerships, Academia-Industry Synergies, Academic-Industry Collaborations, Alain Beaudet: President of Canadian Institutes of Health Research (CIHR), Alice Wong: Minister of State (Seniors) in Canada, Alzheimer Society of Canada, AVIESAN: French National Alliance for Life Sciences and Health, •Alzheimer Society of Canada, Big Data, Biotechnology, Canada, Canada's Research Strategy for Alzheimer's Disease, Canada-France Legacy Event, Canadian Institutes of Health Research (CIHR), Challenge on Dementia, Challenge on Dementia (David Cameron), Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia in Canada, Dementia Innovation, Dementia Research, Dementia Time-Bomb, Dennis Gillings: Former World Dementia Envoy, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Drug Development for Alzheimer's Disease, Drug Discovery Programme, Drug Identification, Drug-Development Pipeline, Faye Forbes (Living With Dementia), France, Free Open Access Journals, G7 Global Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Agreements, G8 Summit on Dementia Communique, G8 Summit on Dementia Declaration, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Dementia Legacy Event on Academia-Industry Synergies, Global Leadership, Global Outlook, Incentives and Investment, Incentives for Drug Development, Innovation, Innovative Medicines Initiative, Institute of Health and Medical Research (Inserm), International Collaborations, International Programmes, Japan Legacy Event, Knowledge Networks, Knowledge Translation, Massachusetts Biotech Cluster: CONNECT, Matthew Dineen (Carer), Medical Devices, Networks, Networks and Alliances, Neurological Research, OECD Big Data and Sustainability Initiative for Large-Scale Research on Dementia, Open Access, Open Access Databases, Open Access Journals, Open Access Knowledge Resources, Open Access Research, Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Pharmaceutical Industry, Pharmacological Research, Philippe Zeller: Ambassador of France to Canada, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Regulatory Barriers: Regulatory Environment, Removing Regulatory Barriers, Research and Innovation, Research Networks, Resource and Incentives, Second Global Dementia Legacy Event, Second Global Dementia Legacy Event (Ottawa: September 2014), The Honourable Rona Ambrose: Minister of Health (Canada), UK Legacy Event, USA Legacy Event, Venture Capital (Approach to Research), World Dementia Council, Yves Lévy: French National Institute of Health and Medical Research (Inserm) and Chairman of Aviesan (French National Alliance for Life Sciences and Health Care)
|
Leave a comment
UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)
Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →
Posted in BBC News, Department of Health, Health Education England (HEE), In the News, International, National, NHS, NHS England, Personalisation, Quick Insights, UK, Universal Interest
|
Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Aarhus University, Akureyri Hospital (Iceland), Astra Zeneca, BBC Health News, Bioinformatics Research Centre: Aarhus University, Biological Treatments, Biotechnology Companies, Birmingham, Broad Institute / Whitehead Institute (Massachusetts), Bubble-Boy Syndrome (Immune Disorders), Call for Global Moratorium on Clinical Uses of Human Germline Editing, Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK (CRUK), Cas9 (Crispr-Associated Protein 9) Enzyme, Cell and Gene Therapy at Institute of Child Health (ICH), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Chief Scientific Officer Bulletin, Chief Scientific Officer Bulletin (July 2014), Children's Hospital: Landspitali University Hospital (Reykjavik Iceland), Cleveland Clinic, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Collaborative Projects, Collaborative Working, Crispr, Crispr-Cas9, CRISPR-Cas9 Genome Editing System, Crisprs (Clustered Regularly Interspaced Short Palindromic Repeats), Cross-Sector Partnerships, David Cameron, deCODE Genetics, deCODE Genetics /Amgen Inc., Decoding Inherited Disorders, Dementia Research, Denmark, Department of Human Genetics: University of Leuven, Department of Internal Medicine: Akureyri Hospital (Iceland), Dilated Cardiomyopathy, Division of Cardiovascular Diseases: Mayo Clinic, DNA Extraction, Dr Francis Collins: Director of National Institutes of Health (USA), Dr Marcy Darnovsky: Center for Genetics and Society (USA), Drugs Targeted at Specific Mutations, Duke University, East Anglian Medical Genetics Service: Cambridge University Hospitals NHS Foundation Trust, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Elimination of Porcine Endogenous Retroviruses Using Crispr, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Ethical Considerations, Ethical Dilemmas, European Bioinformatics Institute, European Bioinformatics Institute: Wellcome Trust Genome Campus, Exeter, Familial Adenomatous Polyposis (FAP), Foetal Stem Cells, Four Ps of Personalised Medicine: Participatory Role for Patients, Four Ps of Personalised Medicine: Precise Diagnoses, Four Ps of Personalised Medicine: Prediction and Prevention of Disease, Four Ps of Personalised Medicine: Targeted and Personalised Interventions, Francis Crick Institute, Fred and Pamela Buffett Cancer Centre (Omaha), Gene Editing in Mice With Duchenne Muscular Dystrophy, Genetic Disorders and Genomics, Genetic Engineering (Pandora's Box), Genetic Modification of Cells: HIV Treatment Strategy, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genome Campus (Wellcome Trust), Genome Sequencing, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomics, Genomics Education Programme, Genomics Education Programme (HEE), Genomics England, Genomics England’s Ethics Advisory Committee, Genomics in the NHS, Genomics-Based Medicine, Genotyping, Germline Alterations (Suggested for DMD Huntington's Disease or Cystic Fibrosis), Germline Editing, Germline Gene Editing, Germline Modification, GM Babies, Great Ormond Street Hospital, Great Ormond Street Hospital (GOSH), Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Harvard University, Health Education England's Genomics Education Programme, HEE: Health Education England, Herceptin, Hinxton Group, Housekeeping Proteins, Human Embryos Edited (August 2017), Human Genetic Disorders, Human Germline Editing, Human Protein Atlas, Hypertrophic Cardiomyopathy, IBM Watson Health, IBM's Watson Supercomputer, Iceland, Icelandic Medical Center (Laeknasetrid), IL2RG Gene, Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Improved Prevention Based on Underlying Predisposition, In Utero Stem Cell Therapy, Innovation in Biotechnology, Innovation in Genetics, Innovative Genomics Initiative (University of California in Berkeley / University of California in San Francisco), Institute of Child Health (ICH), International Summit on Human Gene Editing, Introducing Genomics in Healthcare (Health Education England Video), Knowledge Networks, Knowledge Translation, Knut & Alice Wallenberg Foundation, Knut and Alice Wallenberg Foundation, Laboratory in Mjodd (RAM) Iceland, Landscape of Mutations in Breast Cancer Whole-Genome Sequences, Landspitali University Hospital (Iceland), Large DNA Banks, Large-Scale Whole-Genome Sequencing, Large-Scale Whole-Genome Sequencing (Iceland), Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Lund University, Mayo Clinic (Rochester Minnesota), McDonnell Genome Institute: Washington University (St. Louis), Medical Director of NHS England: Professor Sir Bruce Keogh, Medical Research Council (MRC), Microarrays, Moratorium on Heritable Genome Editing, Mutational Signatures, Mutational Signatures in Breast Cancer, Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres (NHS GMCs), NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North Thames Genomic Medicine Centre, North Thames NHS Genomic Medicine Centre (NHS GMC), North West Coast NHS GMC: Liverpool Women’s NHS Foundation Trust, North West London Healthcare Trust, Nuffield Council on Bioethics, OHSU Knight Cardiovascular Institute, Osteogenesis Imperfecta, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Health Care for Cancer, Personalised Medicine, Personalised Medicine Strategy (NHS England), Personalised Medicine Strategy Board, Personalised Medicine Strategy for the NHS, Personalised Medicine: Improving Outcomes, Peter Grainger: Patient and Public Involvement Representative at St Mark’s Hospital (North West London Healthcare Trust), Pharmaceutical Industry, PHG Foundation, Prof Peter Braude: King's College London, Professor Ian Cumming OBE: HEE Chief Executive, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, Profiling Individual Cancer Genomes (Personalised Medicine), Protein-Coding Cancer Genes, Radboud University, Regional Genetic Laboratories, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Royal Institute of Technology in Sweden, Sanger Institute, School of Engineering and Natural Sciences, Science Working Group: Cancer, Science Working Group: Infectious Diseases, Science Working Group: Rare Diseases, Small and Medium Enterprises (SMEs), SMEs, Somatic Genetic Basis of Breast Cancer, South London NHS GMC: Guy’s and St Thomas’ NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, St Mark’s Hospital, Sun Yat-sen University in Guangdong (China), Talens, Targeted Drugs, Targeted Therapies, Testes, Thermo Fisher Scientific (Massachusetts), Transformational Elements of NHS Genomic Medicine Centres, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University of Iceland, University of Texas MD Anderson Cancer Center, USA, Viv Parry OBE (Science Broadcaster), Wellcome Trust, Wellcome Trust Sanger Institute, Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, Whole Genome Sequencing, Workforce Competencies, Workforce Development, Workforce Training, Xenotransplantation: Avoiding Shortage of Human Donor Organs, Yale Cancer Centre, Zinc fingers
|
Leave a comment
Defeat Dementia Campaign (Alzheimer’s Research UK)
Summary Alzheimer’s Research UK’s “Defeat Dementia” campaign was announced at the Global Dementia Legacy Event on June 19th 2014. Commitments included in the Defeat Dementia programme include: The launch of the Alzheimer’s Research UK Stem Cell Research Centre. There is a £2 … Continue reading →
Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Diagnosis, For Carers (mostly), For Researchers (mostly), In the News, Management of Condition, Quick Insights, UK, Universal Interest
|
Tagged Alzheimer’s Research UK Stem Cell Research Centre, Charitable Funding, Collaborative Projects, Cross-Sector Partnerships, Defeat Dementia Campaign, Defeat Dementia Campaign (Alzheimer’s Research UK), Dementia Challenge, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Research: UK Impact, Drug Discovery Institutes, G8 Dementia Summit, Genetic Research, Genetic Triggers, Global Action Against Dementia, Global Clinical Development Fund, Global Context, Global Dementia Legacy Event, Global Leadership, Global Outlook, Gurdon Institute: University of Cambridge, Innovation in Genetics, Knowledge Networks, Knowledge Translation, Networks, Networks and Alliances, Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Philanthropic Funding, Philanthropy, Research Networks, Stem Cell Research, Stem Cell Research Centre, Translational Research, University College London, University of Cambridge
|
Leave a comment
Public Health England’s Knowledge Strategy (PHE) and Workforce Strategy (Department of Health)
Summary Public Health England (PHE) have published their knowledge strategy, following an extended consultation. Full Text Link Reference Freed, J. Kyffin, R. [and] Rashbass, J. [et al] (2013). Knowledge strategy: harnessing the power of information to improve the public’s health. … Continue reading →
Posted in Commissioning, Community Care, Department of Health, For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Health Education England (HEE), Integrated Care, National, Public Health England, Quick Insights, Standards, UK
|
Tagged Academic Public Health, Advice and Support, Assessing Public Health Interventions, Behaviour Change Opportunities, Behavioural Risk Factors, Cardiovascular Disease (CVD), Central Clearinghouse (PHE Data), Centre for Workforce Intelligence (CfWI), Certificate of Completion of Training (CCT), Changing Behaviours, Chief Knowledge Officer (CKO) Directorate, Communities of Practice, Cost Effectiveness of Public Health Activities, Cost–Benefit Analyses, Cost–Consequences Analyses, Cross-System Modelling, Curriculum Review Steering Group (CRSG), Data and Knowledge Gateway, Data Linkage to Support Surveillance, Data Quality, Data Sharing, Database Searching, Department of Public Health Epidemiology and Biostatistics: University of Birmingham, Development of Knowledge Products, Economic Sustainability, English Local Authorities, Epidemiology, Epidemiology and Statistics, Faculty of Public Health (FPH), Field Epidemiology Service (FES), Future Workforce, Government Digital Strategy, Health and Care Professions Council, Health Education East Midlands (HEEM), Health Informatics, Health Information and Libraries Journal, Health Intelligence Networks, Health Protection Research Units (HPRUs), Healthy Behaviours, Healthy Lifestyles, Healthy Lives Healthy People: Public Health Workforce Strategy, HEE Advisory Group (HEEAG) for Public Health, HEE East Midlands, HEE: Health Education England, Indicators and Indicator Products, Informatics, Information Governance, Information Sharing, Information Storage and Retrieval, Intelligence Networks, Knowledge and Information Workforce, Knowledge and Intelligence (K&I) Staff, Knowledge and Intelligence (K&I) Workforce Strategy, Knowledge and Intelligence Service (KIS), Knowledge and Intelligence Teams (KITs), Knowledge Cycle, Knowledge for Commissioning, Knowledge Generation and Management, Knowledge Networks, Knowledge to Action, Knowledge Translation, Leadership Development, LGA: Local Government Association, Lifestyle Factors, Lifestyle Risk Factors, Linked Datasets, Local Authorities (LAs), Local Authority Public Health, Local Authority-Based Public Health Teams (LAPH), Local Education and Training Board (LETB) Public Health Lead, Local Government, Local Government Association, Local Government Association: LGA, Local Government Leadership Centre, Local Investment in Public Health, Local NHS Organisations, Medical Informatics, Meta-Competence, Metrics, Metrics and Information, Modernising Scientific Careers Programme, Modifiable Risk Factors, National Drugs Treatment Monitoring System (NDTMS), National End of Life Care Intelligence Network, National Health Surveillance Strategy for England, National Institute for Health and Care Excellence (NICE), Networks, Networks in Healthcare, NHS Code of Practice for the Management of Confidential Information, NHS Leadership Academy, NHS Leadership Academy (NHS LA), NICE Public Health Guidance, NIHR PHR: Public Health Research, PHE Briefings, PHE Bulletin, PHE Data and Knowledge Gateway, PHE Digital Strategy, PHE Evidence Reviews, PHE Factsheets, PHE Handbooks, PHE Information Governance Framework, PHE Knowledge Management Framework, PHE Quality Framework for Surveillance, PHE Research and Academic Strategy, PHE: Public Health England, PHE’s Knowledge and Intelligence Teams, PHORCaST: Public Health Online Resource for Careers, Power of Information, Prevention, Prevention of Cardiovascular Disease (CVD), Public Health, Public Health Academic Network, Public Health Challenges, Public Health England (PHE), Public Health Guidance, Public Health Informatics, Public Health Knowledge Products, Public Health Nursing Skills, Public Health Online Resource for Careers Skills and Training (PHORCaST), Public Health Policy and Strategy Unit, Public Health Research, Public Health Skills and Career Framework, Public Health Skills and Knowledge Framework (Formerly the Public Health Skills and Career Framework), Public Health Specialist Training in England Scotland and Wales, Public Health Specialists, Public Health Surveillance, Public Health Surveillance Strategy, Public Health System Talent Management, Public Health Workforce Strategy, Reducing the Burden of Disease and Disability, Registrar-Selected Areas of Optional Special Interest (OSILOs), Risk Factors, Royal College of Physicians: Faculty of Public Health (FPH), Searching for Information on Effectiveness of Public Health Interventions, Searching for Information on Effectiveness of Public Health Interventions: Prevention of Cardiovascular Disease Case Study, Sharing Knowledge and Information, Skills and Training, Skills for System Leadership Programme, Skills Passport Reference Group, Social Epidemiology, Specialist Community Public Health Nurses, Spend and Outcome Tool, Supporting Local Investment in Public Health, Surveillance, Sustainability, Unhealthy Behaviours, Unhealthy Lifestyles, University of Birmingham, Workforce, Workforce Development, Workforce Planning and Development
|
Leave a comment
